On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1450 AM Holland, MI

Weather

Current Conditions(Holland,MI 49422)

More Weather »
42° Feels Like: 37°
Wind: ESE 9 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 33°

Tomorrow

Mostly Sunny 64°

Sun Night

Partly Cloudy 40°

Alerts

Bayer's Nexavar gets priority review as thyroid cancer drug

A plant belonging to Germany's largest drugmaker Bayer is seen in Leverkusen January 30, 2013. REUTERS/Ina Fassbender
A plant belonging to Germany's largest drugmaker Bayer is seen in Leverkusen January 30, 2013. REUTERS/Ina Fassbender

FRANKFURT (Reuters) - Bayer's cancer drug Nexavar was given priority review status by U.S. healthcare regulators for the oral drug's use against a difficult-to-treat type of thyroid cancer, the company said on Tuesday.

The U.S. Food and Drug Administration aims to complete the priority review within six months, rather than the standard review of about 10 months, Bayer said.

Bayer and development partner Onyx Pharmaceuticals are seeking a wider use for Nexavar to include treatment of patients with thyroid cancer that returned despite previous surgery and treatment with radioactive iodine, a group with a particularly poor prospect of survival.

Nexavar is already approved to treat liver as well as kidney cancer and it is also being tested on breast cancer patients.

(Reporting by Ludwig Burger)

Comments